Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado
Numinus Wellness (TSX: NUMI, OTCQB: NUMIF) has achieved a significant milestone as its Psychedelic-Assisted Therapy Training Program received official approval from Colorado state under the Natural Medicine Health Act (Proposition 122). This certification enables the company to train licensed professionals in providing psilocybin services.
The comprehensive certification pathway includes coursework in psychedelic-assisted therapy fundamentals, psilocybin-specific training, trauma-informed care, and practical applications. Healthcare practitioners, including therapists, social workers, and medical professionals, can enroll through an online application process, complete required courses, undergo supervised practicum in Colorado, and pass a final certification exam.
In a corporate update, Numinus disclosed that it has submitted all required information for its year-end financial audit and is working with auditors to complete the process and lift the current cease trade order.
Numinus Wellness (TSX: NUMI, OTCQB: NUMIF) ha raggiunto un traguardo significativo poiché il suo Programma di Formazione per Terapie Assistite da Psichedelici ha ricevuto l'approvazione ufficiale dallo stato del Colorado ai sensi del Natural Medicine Health Act (Proposizione 122). Questa certificazione consente all'azienda di formare professionisti autorizzati nella fornitura di servizi con psilocibina.
Il percorso di certificazione completo include corsi sui fondamenti della terapia assistita da psichedelici, formazione specifica sulla psilocibina, assistenza informata sul trauma e applicazioni pratiche. I professionisti della salute, tra cui terapeuti, assistenti sociali e professionisti medici, possono iscriversi tramite un processo di candidatura online, completare i corsi richiesti, svolgere un tirocinio supervisionato in Colorado e superare un esame finale di certificazione.
In un aggiornamento aziendale, Numinus ha comunicato di aver presentato tutte le informazioni necessarie per la revisione finanziaria di fine anno e sta collaborando con i revisori per completare il processo e revocare l'attuale ordine di cessazione delle operazioni.
Numinus Wellness (TSX: NUMI, OTCQB: NUMIF) ha alcanzado un hito significativo ya que su Programa de Formación en Terapia Asistida por Psicodélicos recibió la aprobación oficial del estado de Colorado bajo la Ley de Salud de Medicina Natural (Proposición 122). Esta certificación permite a la empresa capacitar a profesionales licenciados en la prestación de servicios de psilocibina.
El camino de certificación integral incluye cursos sobre los fundamentos de la terapia asistida por psicodélicos, formación específica en psilocibina, atención informada sobre traumas y aplicaciones prácticas. Los profesionales de la salud, incluidos terapeutas, trabajadores sociales y médicos, pueden inscribirse a través de un proceso de solicitud en línea, completar los cursos requeridos, realizar prácticas supervisadas en Colorado y aprobar un examen final de certificación.
En una actualización corporativa, Numinus reveló que ha presentado toda la información requerida para su auditoría financiera de fin de año y está trabajando con los auditores para completar el proceso y levantar la actual orden de cese de operaciones.
Numinus Wellness (TSX: NUMI, OTCQB: NUMIF)는 자연 의학 건강법 (제안 122)에 따라 콜로라도 주의 공식 승인을 받아 정신 약물 보조 치료 교육 프로그램에서 중요한 이정표를 세웠습니다. 이 인증은 회사가 면허를 가진 전문가들에게 실로시빈 서비스를 제공하는 교육을 할 수 있도록 합니다.
포괄적인 인증 경로는 정신 약물 보조 치료의 기초, 실로시빈 관련 교육, 트라우마 정보 제공 치료 및 실용적인 응용을 포함한 강의로 구성됩니다. 치료사, 사회복지사 및 의료 전문가를 포함한 의료 종사자는 온라인 신청 절차를 통해 등록하고, 필수 과정을 이수하며, 콜로라도에서 감독되는 실습을 수행하고, 최종 인증 시험에 합격할 수 있습니다.
기업 업데이트에서 Numinus는 연말 재무 감사에 필요한 모든 정보를 제출했으며, 감사인과 협력하여 프로세스를 완료하고 현재의 거래 중지 명령을 해제하기 위해 노력하고 있다고 밝혔습니다.
Numinus Wellness (TSX: NUMI, OTCQB: NUMIF) a atteint un jalon significatif puisque son Programme de Formation en Thérapie Assistée par Psychédéliques a reçu l'approbation officielle de l'État du Colorado en vertu de la Loi sur la Santé des Médecines Naturelles (Proposition 122). Cette certification permet à l'entreprise de former des professionnels agréés à la fourniture de services de psilocybine.
Le parcours de certification complet comprend des cours sur les fondamentaux de la thérapie assistée par psychédéliques, une formation spécifique sur la psilocybine, des soins informés sur les traumatismes et des applications pratiques. Les professionnels de la santé, y compris les thérapeutes, les travailleurs sociaux et les professionnels de la santé, peuvent s'inscrire via un processus de candidature en ligne, compléter les cours requis, effectuer un stage supervisé dans le Colorado et réussir un examen final de certification.
Dans une mise à jour d'entreprise, Numinus a révélé qu'elle avait soumis toutes les informations requises pour son audit financier de fin d'année et qu'elle travaillait avec les auditeurs pour finaliser le processus et lever l'ordre de cessation de commerce actuel.
Numinus Wellness (TSX: NUMI, OTCQB: NUMIF) hat einen bedeutenden Meilenstein erreicht, da sein Programm zur Schulung in psychedelisch unterstützter Therapie die offizielle Genehmigung des Bundesstaates Colorado gemäß dem Natural Medicine Health Act (Vorschlag 122) erhalten hat. Diese Zertifizierung ermöglicht es dem Unternehmen, lizenzierte Fachkräfte in der Bereitstellung von Psilocybin-Diensten auszubilden.
Der umfassende Zertifizierungsweg umfasst Lehrveranstaltungen zu den Grundlagen der psychedelisch unterstützten Therapie, spezifische Schulungen zu Psilocybin, trauma-informierte Pflege und praktische Anwendungen. Gesundheitspraktiker, einschließlich Therapeuten, Sozialarbeiter und medizinischer Fachkräfte, können sich über ein Online-Bewerbungsverfahren anmelden, die erforderlichen Kurse absolvieren, ein betreutes Praktikum in Colorado durchführen und eine abschließende Zertifizierungsprüfung bestehen.
In einem Unternehmensupdate gab Numinus bekannt, dass alle erforderlichen Informationen für die Jahresabschlussprüfung eingereicht wurden und dass mit den Prüfern zusammengearbeitet wird, um den Prozess abzuschließen und die aktuelle Handelsstoppanordnung aufzuheben.
- Received state certification in Colorado for psychedelic therapy training program, expanding market presence
- Program approval positions company to generate revenue from healthcare practitioner training
- Company currently under cease trade order pending completion of financial audit
"This is an exciting step forward for both Numinus and for the future of psychedelic-assisted therapy in
Numinus' state-approved certification pathway includes coursework in psychedelic-assisted therapy fundamentals, psilocybin-specific training, trauma-informed care, and practical applications, along with clinical practicum placements to ensure hands-on experience.
"Our program is designed to go beyond the basics, offering experiential learning, trauma-informed care, and somatic practices that prepare facilitators for the nuances of psychedelic-assisted therapy," said Amanda Giesler, Director of Training at Numinus. "By completing our certification, practitioners can enter this field with the knowledge, skills, and ethical grounding to provide safe and impactful care."
The certification pathway is open to various healthcare practitioners, including therapists, social workers, and medical professionals. Applicants submit an online form, enroll in required courses, complete a supervised practicum in
Corporate Update: Year-End Financial Audit & Q1 Review
Numinus has submitted all required information for its year-end financial audit and continues to work diligently with auditors to complete the process. The company remains focused on finalizing its financials and lifting the current cease trade order as soon as possible.
About Numinus
Numinus Wellness Inc. (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus' clinical trial research and comprehensive practitioner training programs are at the forefront of a transformation aimed at healing rather than managing symptoms of depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, and Instagram.
Forward-looking statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect", and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements, and other risks that are set forth in our annual information form dated November 29, 2023, and available on SEDAR at www.sedarplus.ca. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. Numinus does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/numinus-approved-as-a-state-certified-natural-medicine-training-program-in-colorado-302406698.html
SOURCE Numinus Wellness Inc.
FAQ
What does Colorado's approval mean for Numinus (NUMIF) Psychedelic-Assisted Therapy Program?
What are the requirements for healthcare practitioners to complete Numinus's certification program?
What is the current status of Numinus's (NUMIF) financial audit?
What components are included in Numinus's Colorado-approved training program?
